Strategic networks
LUCC has 17 strategic translational networks based on cancer diagnosis, technology or process. The aim of the networks is to bridge the gap between basic and clinical science and between diverse disciplines. Networking activities includes discussion about scientific challenges in the field, facilitation of new collaborations, and to share technical and scholar expertise. The key goal is to create opportunities that set the foundation for novel interdisciplinary research collaboration.
LUCC 16 translational networks (diagnosis, technology, or process-oriented) and respective heads
- Breast (Lao Saal / Sara Alkner)
- Blood, lymphoma & myeloma (Anna Hagström / Stefan Scheding)
- Child (Daniel Bexell / Kees-Jan Pronk)
- UroCan-LUCC (Håkan Axelson / Fredrik Liedberg)
- Brain, spinal cord & pituitary (Alexander Pietras / Johan Bengzon)
- Skin (Göran B Jönsson / Karolin Isaksson)
- Lung (Johan Staaf / Maria Planck)
- Gastrointestinal (Monika Bauden / Daniel Ansari & Pamela Buchwald)
- Sarcoma (Karolina Leandersson Bogefors / Fredrik Mertens)
- Head & neck (Malin Lindstedt / Lennart Greiff & Maria Gebre-Medhin)
- Gynaecology (Ingrid Hedenfalk / Susanne Malander)
- Nursing, rehabilitation and palliative care (Marlene Malmström / Annika Kisch)
- Cancer epidemiology (Helena Jernström / Tanja Stocks)
- Omics, bioinformatics and diagnostics (Kajsa Paulsson / Emma Niméus)
- Imaging & nuclear medicine/radiology (Ramin Massoumi / Ida Dalene Skarping)
- Immunology, tumour microenvironment & metastasis (Karin Leandersson / Anna Sandström Gerdtsson)
- Clinical trials & drug development (Marcus Järås / Ana Carneiro)
Contact resepective head(s) in case you want to participate in any of the strategic translational networks.